CRP and cancer: The value of common conventional inflammatory markers (e.g., C-reactive protein (CRP), white blood cells (WBC), erythrocyte sedimentation rate (ESR) and various ratios of inflammation-related cells, derived from hematology measurements) as prognostic factors has been assessed in various gynecological human cancers—cervical, endometrial, uterine, vulvar, and ovarian cancer [7,8,9,10,11].